MedPath

河南新乡华星药厂

Ownership
-
Established
1986-04-18
Employees
-
Market Cap
-
Website
www.xxhx.com.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

24

NMPA:24

Drug Approvals

Cefazolin Sodium for Injection

Product Name
注射用头孢唑林钠
Approval Number
国药准字H20003026
Approval Date
Dec 24, 2024
NMPA

Benzylpenicillin Potassium

Product Name
青霉素钾
Approval Number
国药准字H41020516
Approval Date
Jun 24, 2020
NMPA

Inosine

Product Name
肌苷
Approval Number
国药准字H41020512
Approval Date
Jun 24, 2020
NMPA

Vitamin B12

Product Name
维生素B12
Approval Number
国药准字H20003008
Approval Date
Jun 24, 2020
NMPA

Lincomycin Hydrochloride

Product Name
盐酸林可霉素
Approval Number
国药准字H41020513
Approval Date
Jun 24, 2020
NMPA

Benzylpenicillin Sodium

Product Name
青霉素钠
Approval Number
国药准字H41020515
Approval Date
Jun 24, 2020
NMPA

Erythromycin

Product Name
红霉素
Approval Number
国药准字H41020517
Approval Date
Jun 24, 2020
NMPA

Ampicillin Sodium

Product Name
氨苄西林钠
Approval Number
国药准字H20003005
Approval Date
Jun 24, 2020
NMPA

Benzylpenicillin Sodium for Injection

Product Name
注射用青霉素钠
Approval Number
国药准字H41020818
Approval Date
May 21, 2020
NMPA

Benzylpenicillin potassium for Injection

Product Name
注射用青霉素钾
Approval Number
国药准字H41020816
Approval Date
May 21, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.